Abstract Context Worldwide, prostate cancer (PCa) represents the second most common
solid tumor in men. Objective To assess the geographical distribution of PCa …

Prostate cancer is the second most frequent cancer diagnosis made in men and the fifth
leading cause of death worldwide. Prostate cancer may be asymptomatic at the early stage …

CONTEXT: Obesity and prostate cancer (PCa) affect substantial proportions of Western
society. Mounting evidence, both epidemiologic and mechanistic, for an association …

Increasing evidence suggested obesity, measured by body mass index (BMI), was
associated with prostate cancer–specific mortality, and its impact on biochemical recurrence …

Obesity is associated with a range of health outcomes that are of clinical and public health
significance, including cancer. Herein, we summarize epidemiologic and preclinical …

Background Excess body-mass index (BMI) has been associated with adverse outcomes in
prostate cancer, and hyperinsulinaemia is a candidate mediator, but prospective data are …

Prostate cancer (PCa) is the most frequently occurring type of malignant tumor and a leading
cause of oncological death in men. PCa is very heterogeneous in terms of grade …

One-third of men with obesity or type 2 diabetes have subnormal free testosterone
concentrations. The lower free testosterone concentrations are observed in obese men at all …

Background: Studies suggest that obesity is associated with lower risk of prostate cancer but
more aggressive cancers. As obesity lowers PSA levels, these observations may be …

The role of testosterone in improving sexual symptoms in men with hypogonadism is well
known. However, recent studies indicate that testosterone plays an important role in several …